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Strengths and limitations of this study
 ► This study is based on national data sets including 
over 100 000 primary hip and knee replacement 
surgeries, with comprehensive data on patient char-
acteristics, comorbidities and mortality.
 ► We used the WHO standard population as the ref-
erence to calculate the age-standardised rates of 
primary hip and knee replacement surgeries, to en-
able international comparisons on age-standardised 
rates of surgeries.
 ► We estimated the 30 days, 90 days and 1 year mor-
tality after surgery, as well as standardised mortality 
ratio (SMR), which is easier for global comparison.
 ► Poisson regression modelling was used to calculate 
the rate ratios of SMR by subgroup after adjustment 
for other factors.
 ► One weakness is that this study does not have data 
on the prevalence of hip and knee osteoarthritis by 
subgroups to identify the reasons for lower rates of 
surgeries in some subgroups.
AbStrACt
Objectives To (1) explore the regional and ethnic 
differences in rates of publicly funded osteoarthritis-
associated hip and knee replacement surgeries and (2) 
investigate the mortality after surgery.
Design Population-based, retrospective, cross-sectional 
study.
Setting General population in New Zealand.
Participants Patients with osteoarthritis who underwent 
publicly funded primary hip and knee replacement surgeries 
in 2005–2017. Patients aged 14–99 years were included.
Primary and secondary outcome measures Age-
standardised rate, standardised mortality ratio (SMR) and 
30 days, 90 days and 1 year mortality.
results We identified 53 439 primary hip replacements 
and 50 072 primary knee replacements with a diagnosis 
of osteoarthritis. The number and age-standardised 
rates of hip and knee replacements increased over time. 
Māori had the highest age-standardised rate of hip 
replacements, followed by European/others and Pacific, 
and Asian had the lowest rate. Pacific had the highest 
age-standardised rate of knee replacements, followed by 
Māori and European/others, and Asian had the lowest rate. 
The Northern Health Network had the lowest rate of hip 
surgeries, and the Southern Health Network had the lowest 
rate of knee surgeries. The SMRs of patients undergoing 
hip and knee replacements were lower than the general 
population: 0.92 (95% CI 0.89 to 0.95) for hip and 0.79 
(95% CI 0.76 to 0.82) for knee. The SMRs were decreasing 
over time. The patterns of 30 days, 90 days and 1 year 
mortality were similar to the SMR.
Conclusions The numbers of publicly funded 
osteoarthritis-associated primary hip and knee 
replacements are steadily increasing. Māori people had 
the highest age-standardised rate of hip replacements and 
Pacific people had the highest rate of knee replacements. 
The Northern Health Network had the lowest rate of hip 
surgeries, and the Southern Health Network had the 
lowest rate of knee surgeries. Compared with the general 
population, patients who had hip and knee replacements 
have a better life expectancy.
IntrODuCtIOn
Osteoarthritis is the most common form 
of arthritis. In New Zealand, osteoarthritis 
affects 10.6% of adults.1 European people 
are more likely to have (12.5%) osteoar-
thritis than Māori (7.1%), Pacific (4.8%) 
and Asian people (2.5%).1 Risk factors of 
osteoarthritis include systemic factors (such 
as genetics, dietary intake, oestrogen use 
and bone density) and local biomechanical 
factors (such as muscle weakness, obesity, 
occupation factors, sports participation and 
joint laxity).2 3 These risk factors partially 
explain the ethnic differences in prevalence 
of osteoarthritis.
Osteoarthritis of the hip and knee is one of 
the most common causes of reduced mobility. 
Hip and knee replacements for osteoarthritis 
can help to alleviate pain and improve func-
tion. The New Zealand Joint Registry (NZJR) 
reported osteoarthritis as the indication 
for 87% and 84% of primary hip and knee 
arthroplasties, respectively.4 Regional and 
ethnic disparities in hip and knee replace-
ment surgeries have been demonstrated in 
other countries.5–12 It has been reported in 
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Australia that total hip and knee replacements are more 
likely to be performed for socially advantaged popula-
tions.13 14 African–Americans, Asians and Hispanics are 
less likely to receive hip and knee replacement surgeries 
than American–European.5 12 Some studies have found 
variations in practice between different regions in New 
Zealand,15–18 but little has been reported in the differ-
ences in access to hip and knee replacement surgeries 
between different regions.
Perioperative mortality is of great importance for 
assessing the safety of interventions, undertaking perfor-
mance assessment and completing quality improvement 
initiatives.19 20 Hip and knee replacement surgeries are 
generally considered to be safe and successful proce-
dures. Short-term and long-term mortality after hip and 
knee replacements has been reported to be lower or 
equivocal to the general population.21–25
The New Zealand healthcare system is a mix of govern-
ment-funded and private healthcare. The public-funded 
system is controlled and managed by the Ministry of 
Health.26 The District Health Boards (DHBs) hold 75% of 
health funding in New Zealand. The public resources are 
limited and are allocated based on prioritisation.27 Before 
2017, the DHBs uses a clinical priority system specific to 
hip and knee primary and revision surgery for prioritising 
patients for surgery.28 Since around 2017, the DHBs have 
shifted to using a generic prioritisation tool called Clin-
ical Priority Assessment Criteria.29 While the same scoring 
tool is used between DHBs, the score required to meet 
the commitment threshold is determined by individual 
DHBs, so varies between regions. It may be adjusted 
throughout the year based on available resources.
This study aims to (1) explore the regional and ethnic 
differences in rates of publicly funded osteoarthritis-as-
sociated hip and knee replacement surgeries and (2) 




This study included patients with osteoarthritis who 
underwent publicly funded primary hip and knee replace-
ment surgeries in 2005–2017. Patients aged between 14 
and 99 years were included. These records were identified 
from the National Minimum Dataset (NMD) that stores 
all publicly funded and some privately funded hospital 
inpatient and day-patient discharge information nation-
ally. The ICD-10-AM ACHI procedure codes (V.3) were 
used to extract the primary hip and knee replacement 
surgeries. These records were cross-referenced with the 
NZJR data to exclude the admissions not for primary hip 
or knee replacement surgery.
The NMD records patient’s diagnosis for the admis-
sion and other comorbidities with a maximum of 30 
diagnostic codes. Patients without a diagnosis of osteoar-
thritis were excluded. Comorbidities for calculating the 
Charlson Comorbidity Index score were identified from 
the diagnostic codes based on the coding algorithms 
developed by Quan et al.30
Data from the NMD were linked to the Mortality Collec-
tion through patients’ National Health Index (NHI) 
numbers.31 The NHI number is a unique identifier that 
is assigned to every person who uses health and disability 
support services in New Zealand. The combined data sets 
included: (1) demographic information: age, gender, 
ethnicity and location (DHBs); (2) treatment information: 
diagnosis, comorbidities and date of surgery; and (3) date 
of death.
Data analyses
Age-standardised rates of primary hip and knee replace-
ment surgeries by gender, ethnicity (Māori, Pacific, Asian 
and European/others) and regional health network 
were calculated using the WHO standard population as 
the reference. There are four health networks in New 
Zealand: Northern Health Network, Midland Health 
Network, Mid Central Health Network and Southern 
Health Network. The Northern Health Network has a 
high Pacific population, the Midland Health Network 
has a high Māori population and is very rural, and the 
Southern Health Network is also rural but with low Māori 
and Pacific populations.32 33
Because the population data by ethnicity and region 
provided by the Ministry of Health and Statistics New 
Zealand33 was only available since 2006, the age-stan-
dardised rates by ethnicity and region were calculated for 
records in 2006–2017. Time trend analysis was performed 
on the number of surgeries as well as the age-standardised 
rates by subgroups.
Standardised mortality ratio (SMR) was estimated 
to compare the relative rate of observed deaths in the 
surgery group to expected deaths in the general popu-
lation. The gender-specific, age-specific and year-spe-
cific mortality rate for the general population were 
from the Statistics New Zealand. The last updated 
date of the Mortality Collection was 31 December 
2015; therefore, SMR was only estimated for patients 
in 2005–2014 to ensure all patients had at least 1-year 
follow-up after surgery. Subgroup analyses on SMR were 
performed by gender, age, ethnicity, Charlson score, 
year of surgery, health network and number of same 
type of surgeries. For patients who had two hip/knee 
(same type) surgeries, the first surgery date was used 
to calculate the SMR. Poisson regression modelling 
was used to calculate the adjusted rate ratios of SMR by 
subgroup. We have also estimated the 30 days, 90 days 
and 1 year mortality after surgery, and examined the 
differences by subgroup. All data cleaning and analyses 
were performed in R V.3.5.0.
Patient and public involvement
There was no active involvement of patients or the 
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Figure 1 Number of publicly funded osteoarthritis-
associated primary hip and knee replacements in 2005–2017.
Figure 2 Age-standardised rates of primary hip replacement 
surgeries by subgroup: (A) overall and by gender; (B) by 
ethnicity; (C) by health network.
reSultS
We identified 60 527 admissions for publicly funded 
primary hip replacements and 52 098 admissions for 
primary knee replacements in 2005–2017 from the 
NMD. After cross-referencing with the NZJR, 500 (0.8%) 
admissions coded for primary hip replacements and 483 
(0.9%) admissions coded for primary knee replacements 
were excluded. Of the eligible surgeries (60 027 primary 
hip surgeries and 51 615 primary knee surgeries), 53 439 
(89.0%) primary hip replacements and 50 072 (97.0%) 
primary knee replacements had a diagnosis of osteo-
arthritis. The number of hip replacements has steadily 
increased from 3283 in 2005 to 5272 in 2017 (by 60.6%), 
and the number of knee replacements increased from 
3093 in 2005 to 5263 in 2017 (by 70.2%) (figure 1). While 
more total hip than total knee replacement surgeries 
were performed in 2005, the total numbers of hip and 
knee replacement surgeries performed per year have 
converged over recent years.
The number of surgeries by ethnicity varied in different 
health network (appendix tables 1 and 2). For primary 
hip replacement surgeries, 17.4% of surgeries in the 
Midland Health Network were performed in Māori 
patients compared with only 4.3% in the Southern Health 
Network. For primary knee replacement surgeries, 
10.0% of surgeries in the Northern Health Network were 
performed in Pacific patients compared with only 0.9% in 
the Southern Health Network and 1.6% in the Midland 
Health Network.
The overall age-standardised rates of hip and knee 
surgeries both increased over time (figures 2 and 3): from 
59.7 per 100 000 in 2005 to 69.8 per 100 000 in 2017 for 
hips, and from 55.1 to 68.1 per 100 000 for knees, respec-
tively. The rates of hip and knee replacement surgeries 
between women and men were similar. There were great 
ethnic disparities in rates of hip and knee replacement 
surgeries. Māori had the highest age-standardised rate 
of hip surgeries (105.6 per 100 000 in 2017), followed by 
European/others (74.0 per 100 000) and Pacific (30.0 
per 100 000), and Asian (5.3 per 100 000) had the lowest 
rate. Pacific had the highest age-standardised rate of 
knee replacements (108.9 per 100 000 in 2017), followed 
by Māori (72.5 per 100 000) and European/others (68.5 
per 100 000), Asian (39.3 per 100 000) had the lowest 
rate. The Northern Health Network had the lowest rate of 
hip surgeries, and the Southern Health Network had the 
lowest rate of knee surgeries.
Patients undergoing hip and knee surgeries had a 
longer life expectancy compared with the general popu-
lation of the same gender and age in recent years. The 
SMRs of patients undergoing hip and knee surgeries 
were 0.92 and 0.79, respectively (table 1). The SMRs were 
decreasing over time, from 1.05 (95% CI 0.97 to 1.13) in 
2005 to 0.62 (95% CI 0.47 to 0.81) in 2014 for hip surgeries, 
and from 0.94 (95% CI 0.87 to 1.01) in 2005 to 0.46 (95% 
CI 0.33 to 0.63) in 2014 for knee surgeries. Women had 
a lower SMR than men and patients aged 70+ years had 
lower SMRs than younger patients, in terms of both hip 
and knee surgeries. The SMRs increased with Charlson 
score, from 0.70 for patients with a Charlson score 0 to 
2.37 for patients with a Charlson score 3+ for hip surgery, 
and from 0.70 for Charlson score 0 to 1.93 for Charlson 
score 3+ for knee surgery. Māori patients undergoing hip 
and knee surgeries had a shorter life expectancy than the 
general population (SMR>1), but all other ethnic groups 
had a longer life expectancy than the general population 
(SMR<1). Patients in the Northern Health Network had 
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Figure 3 Age-standardised rates of primary knee 
replacement surgeries by subgroup: (A) overall and by 
gender; (B) by ethnicity; (C) by health network.
the lowest SMR. Patients who had two hip/knee surgeries 
had a much lower SMR (0.57 and 0.52) than patients who 
only had one hip/knee surgery (0.98 and 0.87).
Poisson regression (table 2) showed that the adjusted 
rate ratio of SMR between men and women was 0.96 (95% 
CI 0.91 to 1.02) for hip replacements and 1.03 (95% CI 
0.97 to 1.10) for knee replacements. Māori patients had 
a higher rate ratio of SMR compared with other ethnic 
groups, and all other health networks had high rate ratios 
(>1) compared with the Northern Health Network. The 
rate ratio decreased with age and year, and increased with 
Charlson score.
The patterns of 30 days, 90 days and 1 year mortality 
after replacement surgery (appendix tables 3 and 4) by 
gender, Charlson score, year and number of surgeries 
were consistent with the SMR. The 30 days, 90 days and 
1 year mortality all increased with age.
DISCuSSIOn
Among the total numbers of publicly and privately 
funded primary hip and knee replacements in 2005–
2016, publicly funded primary hip and knee replace-
ments accounted for 54% and 59%, respectively.4 The 
annual proportion of publicly funded surgeries over the 
total public and private surgeries has been stable. The 
total number of publicly funded hip and knee replace-
ments has been increasing over time as have the age-stan-
dardised rates of surgery.
In a paper by Pabinger and Geissler comparing the 
utilisation rates of hip replacements among 27 OECD 
(Organisation for Economic Co-operation and Devel-
opment) countries,34 New Zealand ranked 17th in 2011 
with a rate of 141 hip replacements per 100 000 total 
population, and Switzerland had the highest rate of 306 
per 100 000, followed by Germany (286 per 100 000) 
and Austria (273 per 100 000). The rates in this paper 
were not age-standardised and included all publicly and 
privately funded surgeries. These explained the differ-
ence between the rate of 141 per 100 000 in Pabinger’s 
paper and the age-standardised rate of 60 per 100 000 in 
our study. Hooper et al35 estimated an age-standardised 
rate of total hip and knee replacements of 285 and 250 
per 100 000, respectively, in 2011 in New Zealand. The 
gaps between Hooper’s and our estimations can be 
explained by all publicly and privately funded surgeries 
included in their study and the population used for 
estimating age-standardised rate, only including people 
aged 35+ years. We decided to use the WHO standard 
population including all age groups as the reference, 
because the Ministry of Health reports all use the WHO 
standard population to calculate the age-standardised 
rates and it enables head-to-head comparisons with over-
seas studies.
Interestingly, we found that Māori people had the 
highest age-standardised rate of publicly funded hip 
surgeries and Pacific people had the highest rate of 
publicly funded knee surgeries. Hooper’s study showed 
that New Zealand Europeans had the highest rate of hip 
replacements and a second-highest rate of knee replace-
ments, which was slightly lower than Pacific people.35 This 
is possibly because New Zealand Europeans are more 
likely to have privately funded surgeries than other ethnic 
groups.36 Asian people had the lowest rate of hip (less 
than 10% the rate for all patients) and knee (58% of the 
rate for all patients) surgeries. This corresponds to the 
low prevalence of osteoarthritis for Asian people (1.9%).1
The Northern Health Network had the lowest rate of 
hip surgeries, and has a high urban population compared 
with the other regions. Research has shown that farmers 
have high rates of hip osteoarthritis,37 and the Northern 
Health Network has a smaller population of rural resi-
dents than other health networks. The Southern Health 
Network had the lowest rate of knee surgeries. This may 
be related to the access problems. The Southern Health 
Network has a big rural population but low Māori and 
Pacific populations who had high needs of primary knee 
replacement surgeries as shown in our results. Other 
reasons may include the variations in the distribution 
of different ethnicities and people of different socio-
economic status in different health network. Socially 
disadvantaged populations are more likely to have better 
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Table 1 Standardised mortality ratio (SMR) of studied patients compared with general population
Subgroups
Primary hip replacement Primary knee replacement
Number of patients SMR (95% CI) Number of patients SMR (95% CI)
Gender
  Female 18 336 0.90 (0.86 to 0.95) 16 205 0.76 (0.72 to 0.81)
  Male 15 797 0.93 (0.89 to 0.98) 14 136 0.82 (0.78 to 0.86)
Ethnicity
  European/others 29 853 0.88 (0.84 to 0.91) 25 692 0.77 (0.74 to 0.80)
  Māori 3671 1.64 (1.43 to 1.89) 2317 1.41 (1.20 to 1.66)
  Pacific 419 1.02 (0.62 to 1.68) 1345 0.76 (0.58 to 1.00)
  Asian 190 0.95 (0.51 to 1.80) 987 0.58 (0.44 to 0.78)
Age (years)
  <40 518 1.81 (0.48 to 6.89) 52 4.72 (0.18 to 127.22)
  40–49 2127 1.32 (0.84 to 2.06) 719 1.35 (0.63 to 2.92)
  50–59 5515 1.37 (1.13 to 1.66) 4681 1.11 (0.90 to 1.38)
  60–69 9924 1.12 (1.02 to 1.23) 10 144 0.88 (0.80 to 0.97)
  70–79 11 300 0.84 (0.80 to 0.89) 10 928 0.74 (0.70 to 0.78)
  80+ 4749 0.88 (0.83 to 0.93) 3817 0.79 (0.75 to 0.84)
Charlson Comorbidity Index
  0 29 663 0.79 (0.76 to 0.82) 25 538 0.70 (0.67 to 0.73)
  1 2236 1.37 (1.24 to 1.52) 2260 1.17 (1.05 to 1.30)
  2 1598 1.68 (1.45 to 1.95) 1874 1.12 (0.96 to 1.30)
  3+ 636 2.37 (1.97 to 2.85) 669 1.93 (1.59 to 2.35)
Year
  2005 3176 1.05 (0.97 to 1.13) 2970 0.94 (0.87 to 1.01)
  2006 3149 1.04 (0.96 to 1.13) 2835 0.86 (0.79 to 0.94)
  2007 3520 0.97 (0.90 to 1.06) 3109 0.84 (0.76 to 0.92)
  2008 3312 0.98 (0.89 to 1.08) 2828 0.79 (0.71 to 0.88)
  2009 3473 0.87 (0.78 to 0.97) 3009 0.84 (0.75 to 0.95)
  2010 3356 0.79 (0.70 to 0.90) 2849 0.66 (0.58 to 0.76)
  2011 3305 0.75 (0.65 to 0.87) 2981 0.68 (0.58 to 0.80)
  2012 3426 0.72 (0.60 to 0.85) 3097 0.49 (0.40 to 0.61)
  2013 3541 0.63 (0.50 to 0.78) 3020 0.47 (0.36 to 0.60)
  2014 3875 0.62 (0.47 to 0.81) 3643 0.46 (0.33 to 0.63)
Health network
  Northern 8956 0.90 (0.83 to 0.96) 9996 0.72 (0.67 to 0.77)
  Mid Central 7040 0.96 (0.89 to 1.04) 6448 0.82 (0.75 to 0.89)
  Midland 8308 0.94 (0.88 to 1.01) 6834 0.84 (0.78 to 0.91)
  Southern 9807 0.88 (0.83 to 0.95) 7046 0.83 (0.77 to 0.89)
  Unknown 22 1.21 (0.25 to 5.84) 17 0.47 (0.05 to 4.65)
Number of same type of surgeries in 2005–2017
  1 28 804 0.98 (0.94 to 1.02) 24 128 0.87 (0.83 to 0.91)
  2 5329 0.57 (0.51 to 0.64) 6213 0.52 (0.47 to 0.57)
Total 34 133 0.92 (0.89 to 0.95) 33 825 0.79 (0.76 to 0.82)
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Table 2 Rate ratios of standardised mortality ratio from Poisson regression model
Variables
Primary hip replacements Primary knee replacements
Rate ratio 95% CI P value Rate ratio 95% CI P value
Gender
  Female Ref Ref
  Male 0.96 0.91 to 1.02 0.216 1.03 0.97 to 1.10 0.308
Ethnicity
  European/others Ref Ref
  Māori 1.61 1.46 to 1.78 <0.001 1.71 1.52 to 1.92 <0.001
  Pacific 0.96 0.67 to 1.39 0.829 0.98 0.79 to 1.22 0.883
  Asian 1.00 0.62 to 1.61 0.997 0.78 0.61 to 0.99 0.045
Age (years)
  <40 Ref Ref
  40–49 0.72 0.31 to 1.69 0.451 0.29 0.07 to 1.28 0.102
  50–59 0.75 0.34 to 1.70 0.494 0.26 0.06 to 1.04 0.058
  60–69 0.60 0.27 to 1.34 0.213 0.21 0.05 to 0.83 0.026
  70–79 0.45 0.20 to 0.99 0.048 0.17 0.04 to 0.68 0.012
  80+ 0.46 0.21 to 1.03 0.060 0.18 0.05 to 0.73 0.016
Charlson Comorbidity 
Index
  0 Ref Ref
  1 1.69 1.55 to 1.84 <0.001 1.63 1.49 to 1.79 <0.001
  2 2.25 2.02 to 2.50 <0.001 1.76 1.56 to 1.98 <0.001
  3+ 3.01 2.66 to 3.41 <0.001 2.88 2.51 to 3.29 <0.001
Year (first surgery date)
  2005 Ref Ref
  2006 0.98 0.89 to 1.07 0.648 0.92 0.83 to 1.01 0.085
  2007 0.92 0.83 to 1.01 0.066 0.89 0.81 to 0.99 0.026
  2008 0.96 0.86 to 1.06 0.378 0.86 0.77 to 0.96 0.009
  2009 0.88 0.79 to 0.98 0.020 0.94 0.84 to 1.06 0.302
  2010 0.81 0.71 to 0.91 <0.001 0.74 0.65 to 0.85 <0.001
  2011 0.75 0.66 to 0.86 <0.001 0.76 0.66 to 0.88 <0.001
  2012 0.69 0.60 to 0.81 <0.001 0.52 0.43 to 0.62 <0.001
  2013 0.56 0.46 to 0.67 <0.001 0.47 0.37 to 0.59 <0.001
  2014 0.56 0.45 to 0.70 <0.001 0.46 0.35 to 0.60 <0.001
Health network
  Northern Ref Ref
  Mid Central 1.08 1.00 to 1.18 0.065 1.10 1.01 to 1.21 0.032
  Midland 1.07 0.99 to 1.16 0.095 1.16 1.06 to 1.26 0.001
  Southern 1.04 0.96 to 1.13 0.298 1.12 1.03 to 1.22 0.008
Number of same type of surgeries in 2005–2017
  One Ref Ref
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access to hip and knee replacements compared with their 
less disadvantaged counterparts.13 14
This study showed that patients who had primary hip 
and knee replacement surgeries had longer life expec-
tancy than the general population (SMR<1). This again 
confirms that hip and knee replacement surgeries are 
safe and successful procedures. This is consistent with 
findings from other studies21 22 24 25 reporting better 
mortality following total hip and knee replacements 
than the general population, although individuals with 
osteoarthritis have a shorter life expectancy.23 Possible 
explanations include selection of healthier individuals to 
undergo surgery and benefits of increased mobility and 
activity levels after surgery.22 25
The high SMR and rate ratio (from Poisson regression) 
for Māori patients can be attributed to the overall shorter 
life expectancy for Māori38 and the SMR was calculated 
by comparing Māori with the general population. The 
gender-specific, age-specific and year-specific mortality 
rate by different ethnic populations were not available. 
This also explains why the Midland Health Network that 
has the highest proportion of Māori patients (15% vs 
4%–10% in other health networks) had the highest SMR. 
For hip replacement surgeries, 19% of Māori patients 
had a Charlson score of 1+ compared with 12% of Euro-
pean/others, and for knee replacements, 23% of Māori 
patients had a Charlson score of 1+ compared with 14% 
of European/others.
Mortality declined with increasing age at surgery, 
which was reported in previous studies assuming younger 
patients may have more comorbidities and higher risk of 
death.22 25 In our cohort, 5% of patients aged less than 
50 years had one or more comorbidities. Other investi-
gators observed a convergence of mortality after 5 years 
following surgery.39 40 This corresponds to the similar 
mortality to the general population (SMR close to 1) for 
patients having surgeries in 2005–2008.
The strength of this study is that it is based on national 
data sets including over 100 000 primary hip and knee 
replacement surgeries. These data sets collect compre-
hensive data on patient characteristics, comorbidities and 
mortality. One weakness is that this study does not have 
data on the prevalence of hip and knee osteoarthritis by 
subgroups. Therefore, we cannot ascertain whether the 
lower rates of surgeries in some subgroups (eg, lower 
rates of hip surgeries in Pacific and Asian people) was 
because of the lower prevalence of hip and knee osteoar-
thritis in these subgroups or barriers of access to public 
health services. The mortality data were only available 
till 31 December 2015, and we could not examine the 
mortality of patients in 2015–2017.
COnCluSIOnS
The numbers of publicly funded osteoarthritis-associated 
primary hip and knee replacement surgeries are steadily 
increasing. Māori people had the highest age-standardised 
rate of publicly funded primary hip replacements and 
Pacific people had the highest rate of publicly funded 
knee replacements. The Northern Health Network had 
the lowest rate of hip surgeries, and the Southern Health 
Network had the lowest rate of knee surgeries. Compared 
with the general population, patients who had hip and 
knee replacements had a better life expectancy.
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